Johnson & Johnson embarks on supply chain restructuring
The project, which is largely tied to the innovative medicine segment, will see the company exit certain facilities and incur costs of up to $750 million.
We haven't written up this one. Supply Chain Dive has the full story — the link below goes straight to it.